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Developmental prosopagnosia (DP) is characterised by a severe, lifelong impairment 
in face recognition. Little work has attempted to improve face processing in these 
individuals, but intriguingly, recent evidence suggests oxytocin can improve face 
processing in both healthy participants and individuals with autism. This study 
examined whether oxytocin could also improve face processing in individuals with 
DP. Ten adults with the condition and 10 matched controls were tested using a 
randomized placebo-controlled double-blind within-subject experimental design (AB-
BA). Each participant took part in two testing sessions where they inhaled 24IU of 
oxytocin or placebo spray and completed two face processing tests: one assessing 
face memory and the other face perception. Results showed main effects of both 
participant group and treatment condition in both face processing tests, but the two 
did not interact. Specifically, the performance of DP participants was significantly 
lower than control performance under both oxytocin and placebo conditions, but 
oxytocin improved processing to a similar extent in both groups.   
 
